Shares gain after encouraging COVID-19 drug data, oil jumps

NEW YORK (Reuters) - A gauge of global stocks climbed on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged.MSCI's gauge of stocks across the globe gained 1.86%. Major U.S. averages rose about 2% in early trading, while the pan-European STOXX 600 index rose 1.40%.Gilead Sciences Inc said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data..